A
Cleveland Bio Labs Inc 73 High Street Category: Pharmaceutical Preparations |
Company representatives
Rachel Levine, Business Development
James Antal, Board Member
Michael Fonstein Phd, President & Chief Executive Officer
Location Type
Headquarters
Revenue
$15,000,000 - $17,500,000
Employees
55
Years In Business
20
Stock symbol
CBLI
State of incorporation
New York
SIC code
873304 (Medical Research)
NAICS code
541711 (Research & Development in Biotechnology)
Rating
Browse U.S. states for Pharmaceutical Preparations
